Form D · Biotechnology

AXIM BIOTECHNOLOGIES, INC.

San Diego, CA · CIK 0001514946

Offering snapshot reported Jun 15, 2020 · SEC filing

Reported sold
$500K
Offering amount: $5M
Investors reported
1
Form D · investor count
Minimum accepted
$100
Reported outside-investor minimum
First sale
Jun 10, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 15, 2020Initial$500,000No comparison1SEC filing
May 21, 2018Initial$600,000No comparison1SEC filing
Oct 23, 2014InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-368905

Source: Form D, filed Jun 15, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dr. George Anastassov Director, Executive
George Anatassov Director, Executive
Maurico Bellora Director
Le Khram Changoer Director, Executive
Lekhram Changoer Director, Executive
Robert L Cunningham Director
John Huemoeller Ii Director, Executive
Robert Malasek Executive
Blake N Schroeder Director
Timothy R Scott Director
Philip Van Damme Director, Executive
Dr. Philip A Van Damme Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6191 Cornerstone Court Suite 117
San Diego, CA, 92121